Hemostasis

Activated Clotting Time (ACT) testing is the gold standard for monitoring heparin therapy during cardiac procedures.
Actalyke instruments and reagents provide the sensitivity, reliability and rapidity needed for timely treatment decisions at the point of care.

The Actalyke XL is a premier analyzer offering excellent reproducibility and strong data handling features. The Actalyke Mini II is the simplest instrument available for activated clotting time testing, yet it retains high sensitivity with performance.

Both Actalyke instruments enable clot detection at the early fibrin formation stage with less variation due to clot fragility. This provides greater precision, especially on highly heparinized and diluted samples.